Passage Bio, Inc.

PASG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Apr 17, 2025
ARS Apr 16, 2025 ARS
DEFA14A Apr 16, 2025 DEFA14A
DEF 14A Apr 16, 2025 DEF 14A
144 Apr 15, 2025
PRE 14A Apr 4, 2025 PRE 14A
4 Mar 18, 2025
4 Mar 18, 2025
4 Mar 18, 2025
424B5 Mar 5, 2025 424B5
S-8 Mar 5, 2025 FORM S-8
10-K Mar 4, 2025 10-K
8-K Mar 4, 2025 8-K
SCHEDULE 13G/A Feb 14, 2025
4 Feb 12, 2025
8-K Jan 31, 2025 FORM 8-K
4 Jan 14, 2025
8-K Jan 10, 2025 FORM 8-K
4 Jan 8, 2025
144 Jan 6, 2025
4 Dec 31, 2024
4 Dec 26, 2024
SCHEDULE 13D/A Dec 26, 2024
4 Dec 11, 2024
4 Dec 6, 2024
← Newer Page 4 of 18 · 442 filings Older →